*
skip to Main Content
enquiries@thearmchairtrader.com

Sign up for our Free Daily Digest newsletter: Actionable insight every morning, designed for the self-directed investor. Find out more

The FTSE has started this morning’s session in a positive fashion, up 0.2% in early trading, helped by a 5% boost by AstraZeneca’s announcement of positive results from their lung cancer drug trials.

LCG Analyst, Ipek Ozkardeskaya noted – “The FTSE 100 found buyers at Friday’s open, as the Bank of England meeting temporarily dented the appetite in the pound market. It seems like the pound traders temporarily abandoned their $1.30 target, after the Bank of England Governor Mark Carney said that the ‘low rates are not excessive’, they are ‘appropriate’. He also added that the wages growth is not expected to be ‘especially fast’, which partially explained the expectations of weaker inflationary pressures moving forward.”

Meanwhile, US equity markets halted their recent run of impressive form, as all three major indices staged their biggest retreat in 3 weeks.

Accendo Markets Analyst, Mike van Dulken commented – “The most notable loser was the Nasdaq, as the tech-focused index broke a streak of four consecutive record high closes on account of Snap Inc-inspired weakness, while a disappointing earnings release from Macy’s saw Retail stocks weigh on both the Dow Jones and S&P 500 ahead of today’s US Retail Sales data release.”

 

In focus today will be Eurozone Industrial Production, forecast to rebound to 0.3% in March from -0.3% in February, back to the levels last seen around the turn of the year. This afternoon, US CPI data is likely to bounce back in April while US Retail Sales are expected to deliver a strong return to growth.

Mike van Dulken also noted – “Retail Sales Ex-Autos should recover from a flat March but the Control Group may slow up a little while Real Average Earnings could steal the show given the Fed’s focus on inflationary pressures.”

Please note this article does not constitute investment advice. Investors are encouraged to do their own research beforehand or consult a professional advisor.

Michael Morton

Michael Morton

Michael has worked within the Financial Industry for more than 20 years. Starting out as a financial analyst, he has extensive experience working with fund management groups and brokerages.

With an interest in Stocks and Shares, Funds, ETFs and Commodities, his investment focus is medium to long term gains, with the objective of financial security on retirement, and building wealth for his young children for their adult life. His broker of choice is Hargreaves Lansdown.

Comments

Back To Top